A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck KGaA partners with C4 Therapeutics in a US$740.0M deal to develop cancer-fighting protein degraders; Merck will finance C4’s discovery work and manage future clinical development

Merck integrates p-Chip's microtransponder technology as a crypto-anchor into cyber-physical trust framework that allows customers to create digital twins of single physical products, prove their authenticity throughout product life cycle

MilliporeSigma opens two new mRNA drug substance manufacturing sites in Germany; the firm is first contract testing, development, and manufacturing company with integrated services for all stages of mRNA development, manufacturing, and commercialization

Merck KGaA’s MilliporeSigma expands its global mRNA network with two new drug substance manufacturing sites in Darmstadt and Hamburg, Germany; the facilities to support all stages of mRNA development and commercialization

Merck wraps up first four years of SMASH Packaging, a global approach based on four pillars--SHRINK, SECURE, SWITCH and SAVE; since SMASH Packaging’s inception, over 100 packaging improvement projects have been completed or are underway

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count